ASCOT Clinical Drug Trials Open for Patient Enrolments
We are excited to announce that the clinical drug trials (ASCOT), which will test the effectiveness of two existing drugs in patients hospitalised with COVID-19, are open for patient enrolments.
The number of hospitals involved has grown to around 70 Australian hospitals, in every state and territory, and over 10 hospitals in New Zealand. The Royal Brisbane and Women’s Hospital (RBWH) Pharmacy is currently distributing the drugs needed for the trials to all hospitals involved.
Due to Australia’s social distancing policies, there are currently less than the expected number of patients available for trial participation, but this may change over the coming months and the research team are also discussing partnerships with international hospitals where infection rates are higher.
Both drugs have shown activity in the test tube against COVID-19, however, more research is needed to test their effectiveness in hospitalised COVID-19 patients. A COVID-19 vaccine is still likely to be 6 to 18 months away, so treatment testing and development is vital.
Thank you to everyone who has donated to the Coronavirus Action Fund and made these trials possible!
We look forward to funding more potentially life-saving COVID-19 medical research projects and will keep you updated about these as they progress.